A new WHO report evaluates global efforts against HIV, viral hepatitis, and STIs, highlighting both significant health achievements and persistent challenges in meeting 2030 targets.
Key facts
- •New HIV infections have fallen by 42% and AIDS-related deaths by 57% since 2010.
- •Viral hepatitis claimed an estimated 1.3 million lives in 2024.
- •Hepatitis B-related deaths have risen by 17% since 2015.
- •Lenacapavir is currently being introduced in 10 countries, with plans for rollout in 14 more.
- •The WHO report identifies service integration within primary health care as a primary strategy for accelerating progress.
The World Health Organization has released a new report assessing progress on its 2022–2030 Global Health Sector Strategies for HIV, viral hepatitis, and sexually transmitted infections. Released at the 26th International AIDS Conference, the report details global health trends, noting that while some areas have seen significant declines in infections and deaths, other sectors face rising rates and funding disruptions that threaten the goal of eliminating these diseases by 2030.
By the numbers
Progress and Challenges in HIV and Hepatitis
By the end of 2025, an estimated 32 million people were receiving HIV treatment, with new infections and AIDS-related deaths falling by 42% and 57% respectively since 2010. However, 9 million people still lack access to treatment, and infections are rising among key populations. Viral hepatitis also shows mixed results; while hepatitis B infections have dropped by 32% since 2015, the disease still claimed 1.3 million lives in 2024, and hepatitis B-related deaths have increased by 17% over the last decade.
STI Trends and Strategic Integration
The global response to STIs remains off track due to rising incidence rates, insufficient HPV vaccination coverage, and increasing antimicrobial resistance, particularly regarding gonorrhea. The WHO report emphasizes that integrating services for HIV, hepatitis, and STIs into primary health care systems is a critical opportunity for progress. This approach, combined with digital health solutions and community-led initiatives, is intended to help countries reach underserved populations and improve surveillance.
New Guidance and Tools for Action
To assist countries in meeting their 2030 goals, the WHO has published new consolidated HIV service delivery guidelines and updated HIV surveillance guidance. These resources provide evidence-based recommendations for organizing prevention, testing, and long-term care. Additionally, the organization is supporting the rollout of new prevention technologies, such as the injectable drug lenacapavir, which is currently being introduced in 10 countries.
Advertisement
This article was independently rewritten by ManyPress editorial AI from reporting originally published by WHO News.
